DR. MICHAEL S DONNENBERG, MD
Osteopathic Medicine at Greene St, Baltimore, MD
License number
Maryland D31679
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(410) 706-7562
(410) 706-8700 (Fax)
(410) 706-8700 (Fax)
Personal information
See more information about MICHAEL S DONNENBERG at radaris.comName
Address
Phone
2840 Saint Paul St, Baltimore, MD 21218
Baltimore, MD
419 Redwood St, Baltimore, MD 21201
419 Redwood, Street, MD 21201
709 34Th St, Baltimore, MD 21211
Professional information
Professor Of Medicine At University Of Maryland School Of Medicine
Position:
Director, Medical Scientist Training Program at University of Maryland School of Medicine, Professor of Medicine at University of Maryland School of Medicine
Location:
Baltimore, Maryland Area
Industry:
Research
Work:
University of Maryland School of Medicine
- Baltimore, Maryland Area since Nov 2012
-
Director, Medical Scientist Training Program
University of Maryland School of Medicine
since Jul 2000
-
Professor of Medicine
University of Maryland School of Medicine
Jul 1995 - Jun 2000
-
Associate Professor of Medicine
University of Maryland School of Medicine
Jul 1990 - Jun 1995
-
Assistant Professor of Medicine
Education:
Columbia University College of Physicians and Surgeons 1979 - 1983
Doctor of Medicine (M.D.) State University of New York at Albany 1976 - 1979
Bachelor of Science (B.S.), Biology
Doctor of Medicine (M.D.) State University of New York at Albany 1976 - 1979
Bachelor of Science (B.S.), Biology
Awards:
Oswald Avery Award
Infectious Diseases Society of America
This honor recognizes members or fellows of IDSA age 45 or younger who have demonstrated outstanding achievements in an area of infectious diseases.
Member
American Society for Clinical Investigation
The ASCI is an honor society of physician-scientists, those who translate findings in the laboratory to the advancement of clinical practice. Founded in 1908, the Society is home to more than 3,000 members who are in the upper ranks of academic medicine and industry.
Fellow, American Academy of Microbiology
American Society for Microbiology
Members of the Academy, known as Fellows, are elected through a highly selective, annual, peer-reviewed process, based on their records of scientific achievement and original contributions that have advanced microbiology.
Carolyn J Pass, MD '65 and Richard M. Susel, MD '66 Academy of Educational Excellence
University of Maryland School of Medicine
Inducted into the inaugural class "The academy is designed to recognize faculty members who demonstrate excellence in bedside, classroom and/or innovative medical and graduate education. Honorees are exemplary role models to students, embody the highest ideals of the medical profession and display uncommon commitment to students’ best interests."
Infectious Diseases Society of America
This honor recognizes members or fellows of IDSA age 45 or younger who have demonstrated outstanding achievements in an area of infectious diseases.
Member
American Society for Clinical Investigation
The ASCI is an honor society of physician-scientists, those who translate findings in the laboratory to the advancement of clinical practice. Founded in 1908, the Society is home to more than 3,000 members who are in the upper ranks of academic medicine and industry.
Fellow, American Academy of Microbiology
American Society for Microbiology
Members of the Academy, known as Fellows, are elected through a highly selective, annual, peer-reviewed process, based on their records of scientific achievement and original contributions that have advanced microbiology.
Carolyn J Pass, MD '65 and Richard M. Susel, MD '66 Academy of Educational Excellence
University of Maryland School of Medicine
Inducted into the inaugural class "The academy is designed to recognize faculty members who demonstrate excellence in bedside, classroom and/or innovative medical and graduate education. Honorees are exemplary role models to students, embody the highest ideals of the medical profession and display uncommon commitment to students’ best interests."
Michael S Donnenberg, Baltimore MD
Specialties:
Infectious Disease Specialist
Address:
22 S Greene St, Baltimore, MD 21201
20 Penn St, Baltimore, MD 21201
20 Penn St, Baltimore, MD 21201
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Tufts Medical Center - Fellowship - Infectious Disease (Internal Medicine)
Johns Hopkins Bayview Medical Center - Residency - Internal Medicine
Tufts Medical Center - Fellowship - Infectious Disease (Internal Medicine)
Johns Hopkins Bayview Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Dr. Michael S Donnenberg, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
20 Penn St SUITE S243, Baltimore 21201
22 S Greene St, Baltimore 21201
(410) 328-5196 (Phone), (410) 706-8700 (Fax)
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
22 S Greene St, Baltimore 21201
(410) 328-5196 (Phone), (410) 706-8700 (Fax)
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
Certifications:
Infectious Disease, 1988, Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
20 Penn St SUITE S243, Baltimore 21201
22 S Greene St, Baltimore 21201
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
22 S Greene St, Baltimore 21201
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1983
Mercy Medical Center
Francis Scott Key Ctr
New Eng Med Ctr
Columbia University / College of Physicians And Surgeons
Graduated: 1983
Mercy Medical Center
Francis Scott Key Ctr
New Eng Med Ctr
Michael Seth Donnenberg, Baltimore MD
Specialties:
Internal Medicine, Infectious Disease, Ophthalmology
Work:
Univ. Of Md Medical Group
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201 Veterans Administration Medical Center
10 N Greene St, Baltimore, MD 21201
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201 Veterans Administration Medical Center
10 N Greene St, Baltimore, MD 21201
Education:
Columbia University (1983)
Pathogenic Escherichia Coli Associated Protein Espa
US Patent:
6355254, Mar 12, 2002
Filed:
Aug 10, 1999
Appl. No.:
09/171517
Inventors:
B. Brett Finlay - Richmond, CA
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD
Li-Ching Lai - Upper Arlington OH
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD
Li-Ching Lai - Upper Arlington OH
Assignee:
University of British Columbia - Vancouver
International Classification:
A61K 39108
US Classification:
4242411, 4241851, 4241901, 530350
Abstract:
The present invention provides the EspA polypeptide, which is secreted by pathogenic such as the enteropathogenic (EPEC) and enterohemorrhagic (EHEC) Diagnosis of disease caused by such pathogenic can be performed by standard techniques, such as those based upon the use of antibodies which bind to EspA to detect the protein, as well as those based on the use of nucleic acid probes for detection of nucleic acids encoding EspA protein. The invention also provides isolated nucleic acid sequences encoding EspA, EspA polypeptide, EspA peptides, a method for producing recombinant EspA, antibodies which bind to EspA, and a kit for the detection of EspA-producing The invention also provides a method of immunizing a host with EspA to induce a protective immune response to EspA.
Engineered Type Iv Pilin Of Clostridium Difficile
US Patent:
2013033, Dec 19, 2013
Filed:
Aug 23, 2013
Appl. No.:
13/974825
Inventors:
Michael Donnenberg - Baltimore MD, US
Assignee:
University of Maryland, Baltimore - Baltimore MD
International Classification:
C07K 14/33, G01N 33/68
US Classification:
4241901, 436501, 435 792
Abstract:
The present invention relates to engineered type IV pilin (tfp) genes, type IV pilin proteins which can serve as a diagnostic marker for identification of patients infected with , and vaccines comprising type IV pilin proteins, antigenic fragments and variants thereof for therapeutic interventions.
Pathogenic Associated Protein
US Patent:
8021861, Sep 20, 2011
Filed:
Mar 29, 2007
Appl. No.:
11/693665
Inventors:
B. Brett Finlay - Richmond, CA
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Assignee:
University of British Columbia
International Classification:
C12P 21/04
US Classification:
435 711, 435 691
Abstract:
The present invention provides a polypeptide, called EspA, which is secreted by pathogenic , such as the enteropathogenic (SPEC) and enterohemorrhagic (EHEC). The invention also provides isolated nucleic acid sequences encoding EspA polypeptide, EspA peptides, a recombinant method for producing recombinant EspA, antibodies which bind to EspA, and a kit for the detection of EspA-producing.
Pathogenic Associated Protein
US Patent:
7214499, May 8, 2007
Filed:
Apr 25, 2006
Appl. No.:
11/411382
Inventors:
B. Brett Finlay - Richmond, CA
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Assignee:
University of British Columbia
International Classification:
G01N 33/554
US Classification:
435 732, 435 71, 5303871, 4242411
Abstract:
The present invention provides a polypeptide, called EspA, which is secreted by pathogenic , such as the enteropathogenic (SPEC) and enterohemorrhagic (EHEC). The invention also provides isolated nucleic acid sequences encoding EspA polypeptide, EspA peptides, a recombinant method for producing recombinant EspA, antibodies which bind to EspA, and a kit for the detection of EspA-producing.
Pathogenic Associated Protein Espa
US Patent:
7078193, Jul 18, 2006
Filed:
Sep 28, 2001
Appl. No.:
09/967347
Inventors:
B. Brett Finlay - Richmond, CA
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Brendan Kenny - Redland, GB
Markus Stein - Quercegrossa, IT
Michael S. Donnenberg - Baltimore MD, US
Li-Ching Lai - Upper Arlington OH, US
Assignee:
University of British Columbia - Vancover
International Classification:
C12P 21/04
US Classification:
435 712, 4353201, 435 691, 435 711, 4352523, 43525233, 536 237, 536 241, 536 2432, 536 2433
Abstract:
The present invention provides a polypeptide, called EspA, which is secreted by pathogenic , such as the enteropathogenic (EPEC) and enterohemorrhagic (EHEC). The invention also provides isolated nucleic acid sequences encoding EspA polypeptide, EspA peptides, a recombinant method for producing recombinant EspA, antibodies which bind to EspA, and a kit for the detection of EspA-producing.
Engineered Type Iv Pilin Of
US Patent:
8518415, Aug 27, 2013
Filed:
May 20, 2010
Appl. No.:
13/321399
Inventors:
Michael Donnenberg - Baltimore MD, US
Assignee:
University of Maryland, Baltimore - Baltimore MD
International Classification:
A61K 39/00, A61K 39/38, A61K 39/02, A61K 39/08
US Classification:
4242391, 4241841, 4241851, 4242341
Abstract:
The present invention relates to engineered type IV pilin (tfp) genes, type IV pilin proteins which can serve as a diagnostic marker for identification of patients infected with , and vaccines comprising type IV pilin proteins, antigenic fragments and variants thereof for therapeutic interventions.